Innovations in Yeast Synthetic Biology: Engineered Discovery Systems for Immunotherapy

Area of Science:

• Synthetic biology
• Immunology
• Protein engineering

Background:

• Yeast-based platforms are increasingly utilized in synthetic biology.
• Discovering immunotherapeutic proteins requires advanced engineering and screening methods.

Purpose of the Study:

• To review innovations in using engineered yeast for discovering and developing protein-based immunotherapeutics.
• To highlight how synthetic biology bridges the gap between basic research and clinical applications in immunoengineering.

Main Methods:

• High-throughput yeast surface display technologies.
• Automated evolution systems (e.g., OrthoRep).
• Computational design strategies for protein engineering.

Main Results:

• Engineered yeast can display proteins like nanobodies for screening antigens.
• Identification of therapeutic binding events for engineered proteins is facilitated.
• Demonstration of yeast enabling new design-build-test-learn (DBTL) workflows.

Conclusions:

• Yeast offers a scalable and programmable chassis for next-generation biotherapeutics.
• Synthetic biology innovations are crucial for advancing immunoengineering.
• Engineered yeast platforms accelerate the development of novel protein therapeutics.